Shares of Aralez Pharmaceuticals Inc (TSE:ARZ) dropped 8.2% during mid-day trading on Friday . The stock traded as low as C$2.00 and last traded at C$2.02. Approximately 11,800 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 30,885 shares. The stock had previously closed at C$2.20.
Separately, HC Wainwright restated a “buy” rating on shares of Aralez Pharmaceuticals in a research report on Monday.
The company has a market cap of $119.06 and a PE ratio of -1.31.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.